|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ando N, Iizuka T, Ide H, Ishida K, Shinoda
M, Nishimaki T, Takiyama W, Watanabe H, Isono K, Aoyama N, et al:
Japan Clinical Oncology Group: Surgery plus chemotherapy compared
with surgery alone for localized squamous cell carcinoma of the
thoracic esophagus: a Japan Clinical Oncology Group Study -
JCOG9204. J Clin Oncol. 21:4592–4596. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Boonstra JJ, Kok TC, Wijnhoven BP, van
Heijl M, van Berge Henegouwen MI, Ten Kate FJ, Siersema PD, Dinjens
WN, van Lanschot JJ, Tilanus HW, et al: Chemotherapy followed by
surgery versus surgery alone in patients with resectable
oesophageal squamous cell carcinoma: long-term results of a
randomized controlled trial. BMC Cancer. 11:1812011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Medical Research Council Oesophageal
Cancer Working Group, . Surgical resection with or without
preoperative chemotherapy in oesophageal cancer: a randomised
controlled trial. Lancet. 359:1727–1733. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kelsen DP, Ginsberg R, Pajak TF, Sheahan
DG, Gunderson L, Mortimer J, Estes N, Haller DG, Ajani J, Kocha W,
et al: Chemotherapy followed by surgery compared with surgery alone
for localized esophageal cancer. N Engl J Med. 339:1979–1984. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lv J, Cao XF, Zhu B, Ji L, Tao L and Wang
DD: Long-term efficacy of perioperative chemoradiotherapy on
esophageal squamous cell carcinoma. World J Gastroenterol.
16:1649–1654. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Metzger R, Bollschweiler E, Drebber U,
Mönig SP, Schröder W, Alakus H, Kocher M, Baldus SE and Hölscher
AH: Neoadjuvant chemoradiotherapy for esophageal cancer: impact on
extracapsular lymph node involvement. World J Gastroenterol.
16:1986–1992. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Campbell NP and Villaflor VM: Neoadjuvant
treatment of esophageal cancer. World J Gastroenterol.
16:3793–3803. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ajani JA, Barthel JS, Bentrem DJ, Damico
TA, Das P, Denlinger CS, Fuchs CS, Gerdes H, Glasgow RE, Hayman JA,
et al: National Comprehensive Cancer Network: Esophageal and
esophagogastric junction cancers. J Natl Compr Canc Netw.
9:830–887. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cunningham D, Allum WH, Stenning SP,
Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ,
Falk SJ, Iveson TJ, et al: MAGIC Trial Participants: Perioperative
chemotherapy versus surgery alone for resectable gastroesophageal
cancer. N Engl J Med. 355:11–20. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kaklamanos IG, Walker GR, Ferry K,
Franceschi D and Livingstone AS: Neoadjuvant treatment for
resectable cancer of the esophagus and the gastroesophageal
junction: a meta-analysis of randomized clinical trials. Ann Surg
Oncol. 10:754–761. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Malthaner R and Fenlon D: Preoperative
chemotherapy for resectable thoracic esophageal cancer. Cochrane
Database Syst Rev: CD001556. 2003. View Article : Google Scholar
|
|
13
|
Urba SG, Orringer MB, Ianettonni M, Hayman
JA and Satoru H: Concurrent cisplatin, paclitaxel, and radiotherapy
as preoperative treatment for patients with locoregional esophageal
carcinoma. Cancer. 98:2177–2183. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Urschel JD and Vasan H: A meta-analysis of
randomized controlled trials that compared neoadjuvant
chemoradiation and surgery to surgery alone for resectable
esophageal cancer. Am J Surg. 185:538–543. 2003. View Article : Google Scholar : PubMed/NCBI
|
